Resistance and Heteroresistance to Colistin in Escherichia coli Isolates from Wenzhou, China

BACKGROUND: Colistin is being administered as last-line therapy for patients that have failed to respond to other available antibiotics that are active against Escherichia coli. The underlying mechanisms of colistin resistance and heteroresistance remain largely uncharacterized. The present study in...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Wenli, Lin, Jie, Jia, Huaiyu, Zhou, Cui, Zhang, Ying, Lin, Yishuai, Ye, Jianzhong, Cao, Jianming, Zhou, Tieli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553605/
https://www.ncbi.nlm.nih.gov/pubmed/33116674
http://dx.doi.org/10.2147/IDR.S273784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553605/
https://www.ncbi.nlm.nih.gov/pubmed/33116674
http://dx.doi.org/10.2147/IDR.S273784

Ejemplares similares